Physician profile
Erick Araneda
NPI 1154323228
$5,217.77
in general payments reported to CMS, 2019-2025
23 companies · $16.97 in 2025
The $16.97 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,487 · 2020: $1,028 · 2021: $1,805 · 2022: $406 · 2023: $331 · 2024: $143 · 2025: $16.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $491.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,407.89 | 2019-2025 | Aveir, Gallant, Merlin@Home |
| Boston Scientific Corporation | $1,328.98 | 2019-2024 | Watchman Access System, Watchman Flx |
| Medtronic Vascular, INC. | $917.82 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $359.54 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $215.58 | 2019-2024 | Lifevest |
| Shockwave Medical, INC | $142.72 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $130.29 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $110.44 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $105.71 | 2019-2021 | |
| Medtronic USA, INC. | $72.49 | 2019-2020 | |
| Pfizer INC. | $64.96 | 2020-2021 | |
| Medtronic, INC. | $54.30 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $53.23 | 2019-2020 | |
| Cardiovascular Systems INC. | $40.00 | 2019 | |
| Biotronik INC. | $39.41 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $38.32 | 2021 | |
| Abiomed | $37.80 | 2019-2020 | |
| Amgen INC. | $21.22 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $17.78 | 2019 | |
| Lantheus Medical Imaging, INC. | $16.22 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.16 | 2019 | |
| Biosense Webster, INC. | $14.62 | 2021 | |
| Terumo Medical Corporation | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erick Araneda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.